VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding VivoSim Labs, INC. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 46 | 51 | +5 |
| Shares | 2.40M | 2.29M | −109.9K (−4.6%) |
| Value | $23.1M | $21.4M | −$1.74M (−7.5%) |
New holders (11)
Institutions that held VivoSim Labs, INC. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Commonwealth Equity Services, LLC | 30,008 | $282.0K | 0.00% |
| State Street Corp | 27,831 | $262.0K | 0.00% |
| Credit Suisse AG | 15,607 | $147.0K | 0.00% |
| Dimensional Fund Advisors LP | 12,363 | $116.0K | 0.00% |
| Albion Financial Group | 1,912 | $18.0K | 0.00% |
| Spire Wealth Management | 1,000 | $9.00K | 0.00% |
| North Star Investment Management Corp. | 750 | $7.00K | 0.00% |
| Wealth Quarterback LLC | 225 | $3.00K | 0.00% |
| Captrust Financial Advisors | 40 | $0 | 0.00% |
| Advisory Services Network, LLC | 30 | $0 | 0.00% |
| Strategic Blueprint, LLC | 15 | $0 | 0.00% |
Sold out (6)
Institutions that held VivoSim Labs, INC. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Goldman Sachs Group Inc | 17,255 | $166.0K |
| Jump Financial, LLC | 13,000 | $125.0K |
| Citadel Advisors LLC | 10,384 | $100.0K |
| Wealthcare Advisory Partners LLC | 809 | $8.00K |
| Eudaimonia Partners, LLC | 81 | $1.00K |
| Valeo Financial Advisors, LLC | 17 | $0 |